Global Reagent Access Kerafast offers a platform to access unique lab-made reagents from over 170 institutions worldwide, presenting an opportunity to pitch expansion into additional institutions and recurring procurement partnerships.

Royalty-backed Partnerships The business model includes handling selling logistics and returning royalties to providing labs, which can be positioned as a low-risk, high-margin channel for universities and research labs to monetize their inventories.

Antibody Focus Post-merger with Absolute Antibody and integration into Absolute Biotech, there is a strong emphasis on recombinant antibody technology, suggesting a cross-sell opportunity to researchers seeking antibody reagents and related services.

Lightweight Brand Footprint With a small employee base, limited direct sales bandwidth likely exists; strategic partnerships with distributors or targeted outreach to mid-size labs could unlock scalable growth without heavy headcount.

Strategic Collaborations Past collaborations with academic and nonprofit organizations indicate openness to new partnerships; targeting biotech startups, education institutions, and animal health/biotech research groups could yield timely sales opportunities.